Letters by company
Noble Corp plc
6 letters discussing NE. Everything written about it on this site is on its ticker page.
- First Eagle Investments Global Equity ETF Commentary Global Equity ETF commentary argues that easy financial conditions, AI infrastructure spending and household dissaving support earnings but leave markets vulnerable, while gold retains strategic hedging value amid fiscal strain. It attributes gains to Samsung, Alphabet and health-care holdings, and maintains conviction in Noble, Charter, HCA, Exxon and Agnico despite sector pressures. second quarter 2026 0R1M $888BAEM $93BCHTR $13B
- Patient Capital Management 1Q26 Portfolio Activity & Attribution Patient Opportunity Equity Strategy initiated Adobe and iShares Bitcoin Trust ETF, replacing its Fidelity bitcoin fund exposure, while selling Alibaba, Mattel and Peloton after reassessing valuations and funding new ideas. The strategy argues that its energy holdings offer an anti-fragile diversifier, and increased UnitedHealth after its Medicare reimbursement-driven selloff. 1Q26 ADBE $90BCHYM $11BIBIT $173B
- Patient Capital Management 2Q25 Portfolio Activity and Attribution Patient Opportunity Equity Strategy added UnitedHealth, Noble, Tempus AI, Clear Secure and Costco puts, while exiting New Fortress Energy over deteriorating fundamentals and balance-sheet strain. It expects tighter offshore-rig supply to favor Noble, sees UnitedHealth as a durable platform after Medicare Advantage setbacks, and backs Tempus’s AI-enabled molecular-data business. 2Q25 BABA $270BCOIN $47BCOST $418B
- Azvalor Asset Management Letter to investors 1H2026 Azvalor argues that speculative activity and leveraged products have created unusually fertile conditions for value investors, while broad equity indices look expensive relative to short-term government bills. The firm rotates out of appreciated holdings into deeply discounted ideas, added Yellow Cake and Borr Drilling, sold Tenaris, and cites a growing research team and idea pipeline as support for portfolio renewal. first half of 2026 —
- Patient Capital Management 2Q26 Portfolio Activity & Attribution Opportunity Equity added Adyen, Global Payments, Genius Sports, Fidelity Wise Origin Bitcoin Fund and QXO preferred securities while exiting IBIT, Noble and Dave & Buster's. The strategy argues that depressed expectations create value in health care, payments, biotech and selected software, while retaining conviction in QXO's building-products consolidation strategy. second quarter of 2026 ADBE $90BADYEN $31BBIIB $33B
- Broyhill Asset Management The Broyhill Letter Q2 2025 Broyhill’s equity strategy added to Dollar Tree after tariff-driven selling and trimmed Philip Morris while retaining it as its largest holding. It shifted part of Avantor into Thermo Fisher, increased Fiserv after its selloff, and initiated IQVIA. The firm consolidated offshore exposure into Noble and favors undervalued smaller, international, and healthcare businesses. 2025.Q2 AVTR $11BDLTR $22BIQV $42B
